BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32266268)

  • 1. Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy.
    Kholia S; Herrera Sanchez MB; Cedrino M; Papadimitriou E; Tapparo M; Deregibus MC; Bruno S; Antico F; Brizzi MF; Quesenberry PJ; Camussi G
    Front Cell Dev Biol; 2020; 8():188. PubMed ID: 32266268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Liver Stem Cell-Derived Extracellular Vesicles Prevent Aristolochic Acid-Induced Kidney Fibrosis.
    Kholia S; Herrera Sanchez MB; Cedrino M; Papadimitriou E; Tapparo M; Deregibus MC; Brizzi MF; Tetta C; Camussi G
    Front Immunol; 2018; 9():1639. PubMed ID: 30072992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Liver Stem Cell Derived Extracellular Vesicles Alleviate Kidney Fibrosis by Interfering with the β-Catenin Pathway through miR29b.
    Kholia S; Herrera Sanchez MB; Deregibus MC; Sassoè-Pognetto M; Camussi G; Brizzi MF
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound enhances the therapeutic potential of mesenchymal stem cells wrapped in greater omentum for aristolochic acid nephropathy.
    Yang Y; Geng X; Chi K; Liu C; Liu R; Chen X; Hong Q; Cai G
    Stem Cell Res Ther; 2021 May; 12(1):261. PubMed ID: 33941258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease.
    Wang Y; Guo YF; Fu GP; Guan C; Zhang X; Yang DG; Shi YC
    Stem Cell Res Ther; 2020 Jul; 11(1):274. PubMed ID: 32641100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy.
    Grange C; Tritta S; Tapparo M; Cedrino M; Tetta C; Camussi G; Brizzi MF
    Sci Rep; 2019 Mar; 9(1):4468. PubMed ID: 30872726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Evaluation of Anti-Fibrotic Effect of Tissue Specific Mesenchymal Stem Cells Derived Extracellular Vesicles for the Amelioration of CCl4 Induced Chronic Liver Injury.
    Gupta S; Pinky ; Vishal ; Sharma H; Soni N; Rao EP; Dalela M; Yadav A; Nautiyal N; Kumar A; Nayak B; Banerjee A; Dinda AK; Mohanty S
    Stem Cell Rev Rep; 2022 Mar; 18(3):1097-1112. PubMed ID: 34859376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury.
    Birtwistle L; Chen XM; Pollock C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34202940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model.
    Gholampour MA; Abroun S; Nieuwland R; Mowla SJ; Soudi S
    J Cell Physiol; 2021 Aug; 236(8):6055-6067. PubMed ID: 33492726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oct-4 Enhanced the Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Acute Kidney Injury.
    Zhang ZY; Hou YP; Zou XY; Xing XY; Ju GQ; Zhong L; Sun J
    Kidney Blood Press Res; 2020; 45(1):95-108. PubMed ID: 31927554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation.
    Du C; Xu C; Jia P; Cai N; Zhang Z; Meng W; Chen L; Zhou Z; Wang Q; Feng R; Li J; Meng X; Huang C; Ma T
    Elife; 2024 Feb; 13():. PubMed ID: 38314821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury.
    Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G
    Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of relaxin in a mouse model of aristolochic acid nephropathy.
    Yang X; Thorngren D; Chen Q; Wang M; Xie X
    Biomed Pharmacother; 2019 Jul; 115():108917. PubMed ID: 31060002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection.
    Hamano Y; Aoki T; Shirai R; Hatano M; Kimura R; Ogawa M; Yokosuka O; Ueda S
    Nephron Exp Nephrol; 2010; 114(2):e69-81. PubMed ID: 19907192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity Blunts the Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles.
    Huang W; Hong S; Zhu X; Alsaeedi MH; Tang H; Krier JD; Gandhi D; Jordan KL; Saadiq IM; Jiang Y; Eirin A; Lerman LO
    Kidney Int Rep; 2023 Sep; 8(9):1841-1851. PubMed ID: 37705914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B
    Navarro Garrido A; Kim YC; Oe Y; Zhang H; Crespo-Masip M; Goodluck HA; Kanoo S; Sanders PW; Bröer S; Vallon V
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F455-F467. PubMed ID: 35979966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation.
    Gao Z; Zhang C; Peng F; Chen Q; Zhao Y; Chen L; Wang X; Chen X
    Stem Cell Res Ther; 2022 May; 13(1):191. PubMed ID: 35526054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases.
    Didamoony MA; Soubh AA; Atwa AM; Ahmed LA
    Inflammopharmacology; 2023 Dec; 31(6):2973-2993. PubMed ID: 37874430
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Cao H; Cheng Y; Gao H; Zhuang J; Zhang W; Bian Q; Wang F; Du Y; Li Z; Kong D; Ding D; Wang Y
    ACS Nano; 2020 Apr; 14(4):4014-4026. PubMed ID: 32212674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.